Galderma Laboratories’ Tri-Luma Cream, the only FDA-approved triple combination topical product indicated for the short-term (up to 8 weeks) treatment of moderate to severe melasma of the face, is now available via at pharmacies, which allows doctors to write prescriptions for the more than 7 million people who suffer from this chronic skin condition. Melasma causes the appearance of brown to gray-brown patches of skin due to the body producing too much melanin, a natural substance that giv...